Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of Hematopoietic Stem Cells in Acute Myocardial Infarction (TECAM2)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by TECAM Group.
Recruitment status was  Recruiting
Study NCT00984178   Information provided by TECAM Group

First Received on September 24, 2009.   Last Updated on February 1, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Infarction
Myocardial Infarction
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Ischemia
Myocardial Ischemia
Necrosis
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Bone marrow mononuclear cells
Additional drug interventions recognized in this trial
Lenograstim
More general drug interventions related to this trial
Adjuvants, Immunologic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
TECAM Group
Hospital General Universitario Gregorio Marañon


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services